Human tumor cell death during radiotherapy is caused mainly by ionizing radiation (IR)-induced DNA double strand breaks (DSBs), which are repaired by either homologous recombination repair (HRR) or non-homologous end-joining (NHEJ). Although siRNA-mediated knockdown of DNA DSB repair genes can sensitize tumor cells to IR, this approach is limited by inefficiencies of gene silencing. In this study, we demonstrate that combining an artificial microRNA (amiR) engineered to target 3'-untranslated regions of XRCC2 (a HRR factor) or XRCC4 (a NHEJ factor) along with an siRNA to target the gene coding region can improve silencing efficiencies to achieve more robust radiosensitization than single approaches alone.
Introduction
Radiotherapy, one of the leading approaches in cancer therapy, contributes to more than 50% of cancer treatment. Ionizing radiation (IR) kills tumor cells mainly by inducing DNA double strand breaks (DSBs) and, therefore, results in cell reproductive death (loss of the capacity to sustain proliferation) (1, 2) . Therefore, inhibiting DNA DSB repair is an efficient way to sensitize human cells to IR-induced killing. In mammalian cells, there are two pathways to repair DNA DSB: homologous recombination repair (HRR) and non-homologous end-joining (NHEJ). XRCC4 is an essential factor that stimulates DNA ligase IV in the NHEJ pathway (3, 4) on April 15, 2017. © 2012 American Association for Cancer Research. cancerres.aacrjournals.org Downloaded from Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on January 11, 2012; DOI: 10.1158/0008-5472. CAN-11-2785 and XRCC2 is an essential factor in the HRR pathway (5, 6) . Targeting the XRCC4 coding region with siRNA has been reported to manipulate the NHEJ pathway (7) and targeting the XRCC2 coding region with siRNA has been reported to affect the HRR pathway (8) . Many human tumors have a strong DNA DSB repair capacity; therefore, discovering a new approach that could target DNA repair genes more efficiently is essential to maximally sensitize human tumor cells to IR-induced killing.
MicroRNAs (miRNAs) are evolutionally conserved non-coding ~19-23 nucleotide RNAs that negatively regulate gene expression by binding to the 3'-untranslated region (UTR) of target genes (9, 10) . It has been demonstrated that the artificial microRNA (amiR) could be used for silencing gene expression by targeting its 3'-UTR (11) . We were interested in testing the hypothesis that combining amiR to target the 3'-UTR of the DNA repair gene and siRNA to target the coding sequence of the same gene could maximally knock down the gene. In this study, we chose XRCC4 and XRCC2 as the target genes to test whether we could use the combined approach to maximally knock down the genes and sensitize human tumor cells to IRinduced killing. Our data showed promising results and demonstrated the feasibility and efficiency of the combined approach for these repair genes. We believe that this combined approach is also very useful for many other gene targeting purposes, especially for some genes that are difficult to target using a single approach (either siRNA or amiR).
Materials and Methods

Human tissues, tumor cell lines and irradiation
The frozen human brain non-tumor tissues and glioblastoma (GBM) samples were derived from brain surgeries at Emory University. Human brain tumor cell lines (U87MG and T98G) and (13) . The human non-tumor cell lines: HBEC-3KT and LN229, were cultured as described previously (12, 13) and verified by a soft agar colony-forming assay. IR was carried out using an X-ray machine (X-RAD 320, N. Branford 320 kV, 10 mA, the filtration with 2 mm aluminum) in our laboratory. The dose rates were about 2 Gy/min.
Construction of amiR expressing plasmid
The XRCC4 or XRCC2 specific amiR was designed by a BLOCK-iT TM RNAi Designer tool and purchased from Invitrogen. A BLAST analysis was performed to avoid the designed sequence with substantial homology to other genes. The primers are shown in the Supplementary   Table S1 . The double strand oligos were generated by annealing equal amounts of each single strand oligo and cloned into a pcDNA TM 6.2-GW/EmGFP-miR vector. After the sequence was verified, the amiR expression clone was inserted into the destination vector pLenti6/V5-DEST (Invitogen) according to the manufacturer's instructions.
Lentivirus packaging and infection
These experiments were similar to that described previously (14, 15) . Briefly, approximately 
siRNA and mimic amiR transfection
The control RNA and siRNA pool against human XRCC4 or XRCC2 were purchased from Santa Cruz Biotechnology Inc. The amiR mimic and single siRNA against human XRCC4 or XRCC2 were purchased from Qiagen. The sequence of siRNA against human XRCC4 (Cat. # 
Quantitative real-time PCR
Total small RNA in the human tumor cells were extracted by using a Qiazol kit (Qiagen).
RNA (1 ȝg) was used to synthesize cDNA by using a SuperScript III kit (Invitrogen) according to the manufacturer's instructions. Real-time PCR was performed on a SDS 7500 Fast Instrument (Applied Biosystems) with the System Software version 2.0.5 following the default cycling protocol (at 95°C for 10 min, followed by 40 cycles of 95°C for 15 s, and 60°C for 1 min). Fluorescence readings were taken during the 60°C step. Primers (Supplementary Table S1) for XRCC4, XRCC2 or ȕ-actin (an endogenous control) mRNA were designed using Primer Express 3.0 software (Applied Biosystems). RQs were calculated using the ǻǻCt method.
Quantitative RT-PCR was performed at least three times and a no-template control was included as a negative control.
Luciferase assay
Similar to the methods as described in our previous studies (14, 15) , 293FT cells were transfected with the plasmids (encoding the 3'-UTR of XRCC2 or XRCC4 containing the potential amiR binding site or the site was deleted) with or without 100 nM amiR mimics (Qiagen) in 48-well plates. The primers used for the experiments are listed in the supplementary table S2. The cells were harvested 48 h after transfection, the cells were then lysed with a luciferase assay kit (Promega) according to the manufacturer's protocol and were measured on a luminescence microplate reader LUMIstar Galaxy (BMG labtechnologies). β-galactosidase or renilla luciferase was used for normalization.
Western blot
Whole cell lyses for Western blot were prepared as described previously (14, 15) . The antibodies against XRCC4, XRCC2 and ȕ-actin were purchased from Santa Cruz Biotechnology.
The antibodies against XRCC4, XRCC2 and ȕ-actin were purchased from Santa Cruz 
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Biotechnology Inc and incubated overnight at 4°C. The membrane was scanned and analyzed using an Odyssey Infrared Imaging System (LI-COR Bioscicences).
Gamma H2AX (γ-H2AX) foci assay
The assay followed the previously reported protocol (16, 17) for camera control, image acquisition, processing and a module for multi-channel display.
Clonogenic surviving assay
Cellular sensitivity to radiation was determined by the loss of colony-forming ability as described previously (14, 15 The results also showed higher expression levels of XRCC2 or XRCC4 in the human GBM tissues than in their non-tumor counterpart tissues (Fig. 1B) . These data suggest that it might be common that these repair genes highly express in human tumors and, therefore, knocking down these genes could be particularly benefit from the tumor radio-sensitization. Based on these data, we chose U87MG (human GBM cell line) and A549 (human lung cancer cell line) cells in our following experiments because the levels of XRCC2 and XRCC4 were relatively higher in these two cell lines (framed lanes in Fig. 1A ) when compared with the normal human cells and other human brain and lung tumor cell lines tested. After choosing the candidate genes and cell lines, we designed the amiR that targets XRCC2 or XRCC4 and examined the effects of the amiR on knocking down the targeted genes because siRNA is a relatively mature approach for knocking down a gene.
The amiR against XRCC4 or XRCC2 efficiently inhibited the targeted gene expression
Natural mammalian miRNA only requires 6-8 seed nucleotides to match the sequence of the targeted gene 3'-UTR, therefore, one miRNA could target multiple mRNAs. To avoid the nonspecific effects, we decided to choose the completely matched strategy (the amiR completely matched the target sequence). Based on the sequence of XRCC2 or XRCC4 3'-UTR, we identified the potential targeted sequences of 3'-UTR that could be bound by an amiR (Fig. 2A) .
Based on the information, we designed the construct encoding the precursor of amiR against XRCC4 or XRCC2 (Fig. 2B ) and inserted the sequences into a lentiviral vector as we described previously (14, 15) . To examine whether the sequence in the 3'-UTR of XRCC2 or XRCC4 could be bound by the amiR, we performed the luciferase assay. The results showed that the amiR could bind well to the targeted sequence (Fig. 2C) , suggesting the amiR could work as a miRNA to decrease the targeted gene expression. We then infected the plasmid encoding amiR-XRCC2, amiR-XRCC4 or both into U87MG or A549 cells. After using the antibiotic selection for 10 generations, we obtained the amiR stably expressed cells that showed the positive GFP signals that reflected the amiR expression frequency of >80% (Fig. 3A) . We next examined the levels of the targeted protein: XRCC2 and XRCC4 in these cells. The results showed that the miRs efficiently reduced their targeted gene expression in both U87MG and A549 cells ( 
3B), indicating that our designed amiRs worked well even in cells that were co-infected with the two vectors (Fig. 3B) . After we obtained the amiR stably expressed cells, we examined the effects of the amiR on the proliferation (by growth curve) and clonogenic rate (plating efficiency) in these cells without any treatment. The results showed that when compared with non-infected cells and the vector alone infected cells, the vector encoding amiR infected cells showed similar proliferation (Supplementary Fig. S1A ) and clonogenic rates ( Supplementary   Fig. S1B ), indicating that the amiR expression alone had less toxicity. In addition, when the cells that were sub-cultured for a relatively long time, the target genes were still inhibited ( Supplementary Fig. S2A ) and the cells still showed more sensitive to IR-induced killing than their vector alone infected cells (Supplementary Fig. S2B ). These results suggest that although a lower level of the DNA repair gene does not affect normal survival of the cells, it does radiosensitize the cells.
The amiR against XRCC4 or XRCC2 efficiently sensitized human tumor cells to IRinduced killing
Next, we examined the effects of the amiR on the radio-sensitization of the cells. We used a γ-H2AX assay to examine the DNA DSB repair efficiency because the signals of γ-H2AX reflect the amounts of DNA DSBs in irradiated cells (16, 18) and indirectly describe the efficiency of DNA DSB repair (17) . The results showed that there was no apparent difference in the γ-H2AX positive ratios among the examined cells immediately after IR (30 min), suggesting that there was not much difference in the induction of DNA DSB in these irradiated cells, however, the γ-H2AX positive ratios clearly increased in the irradiated cells expressing amiR-XRCC2 or amiR-XRCC4 when compared with the irradiated cells transfected with the vector alone (Fig. 4A, B) . 
The γ-H2AX positive ratios left even more in the irradiated cells expressing both amiR-XRCC2 and amiR-XRCC4 than in the irradiated cells expressing amiR-XRCC2 or amiR-XRCC4 alone (Fig. 4A, B) . These results indicate the amiRs inhibited the DNA DSB repair, which is further supported by the survival data (using a clonogenic assay to examine the reproductive death). The results showed that IR killed more cells expressing either amiR-XRCC4 or amiR-XRCC2 than the cells expressing the vector alone, and killed even more of the cells expressing both amiR-XRCC2 and amiR-XRCC4 than the cells expressing amiR-XRCC2 or amiR-XRCC4 alone (Fig.   4C ). These results demonstrate that the amiRs could be used to target DNA repair genes in human tumor cells and sensitize these tumor cells to IR-induced killing. Next, we were interested in detecting the effects of siRNA on targeting the same gene in the tumor cells expressed with the amiR and study whether the combination approach could enhance the gene knock down efficiency and the human tumor cell radio-sensitization.
Combining amiR and siRNA to target XRCC2 or XRCC4 more efficiently knocked down the gene and radio-sensitized the human tumor cells
To find a better time for gene targeting, we examined the XRCC2 or XRCC4 levels in U87MG or A549 cells expressed with the amiR-XRCC2 or amiR-XRCC4 at different times after the cells were treated with siRNA against XRCC2 or XRCC4. The results showed that the control RNA did not affect the targeted gene expression at all time points but the siRNA maximally inhibited the targeted gene at 72h after transfection in these tumor cells and inhibited more XRCC2 or XRCC4 expression in A549 or U87MG cells stably expressed with the amiR (against XRCC2 or XRCC4) (Fig. 5A) . These results indicate that the combined approach is more efficient than the siRNA or amiR approach alone. We then examined the sensitivities of the combined approach on cell radio-sensitivity. The results showed that the cell sensitivity levels depended on the XRCC2 or XRCC4 level: the siRNA against XRCC2 or XRCC4 more efficiently sensitized A549 or U87MG cells expressing the amiR-XRCC2 or amiR-XRCC4 than the cells containing the vector alone (Fig. 5B) . These results further demonstrate that the combined approach is more efficient than the siRNA or amiR approach alone.
Knocking down XRCC2 or XRCC4 by combining small RNAs to target both coding region and 3'-UTR is through increasing the mRNA degradation and inhibiting the translation
Some commercially available siRNA pools (for targeting a small gene that contains a short coding region) include a small RNA that targets the 3'UTR of the gene. The small RNA that targets the 3'UTR of the gene looks like a miRNA mimic and is a stable double-strand RNA with ~22 nucleotides. However, there are no commercially available siRNA pools that include small RNAs to target 3'-UTR of XRCC2 or XRCC4. Also, there is no report to compare the efficiency of any such combined approach (targeting both coding region and 3'-UTR of a gene) with the single approach (targeting coding region or 3'-UTR of a gene) on knocking down a gene. In addition, there is no mechanism study for elucidating the advantage of the combined approach if it does have some advantages on the gene knock down. Therefore, we next investigated the effects of the small RNA combined approach (targeting both non-coding and coding regions of XRCC2 or XRCC4) by mixing the amiR mimic and siRNAs against XRCC2 or XRCC4. We also tried to elucidate how the targeted gene was knocked down by the combined approach if the combined approach did show a better effect on knocking down the repair gene than the siRNA or amiR mimic alone. The results showed that an amiR mimic specifically knocked down XRCC2 or XRCC4 (Fig. 6A) , and mixing it with a siRNA more efficiently (Fig. 6A) . As expected, mixing amiR mimic with siRNA against XRCC2 or XRCC4 more efficiently sensitized the cells to IR-induced killing than using amiR or siRNA against XRCC2 or XRCC4 alone (Fig. 6B) . These results provide strong evidence that using the small RNAs to target both the non-coding and coding regions of a gene could more efficiently knock down the targeted gene.
Since miRNA could either decrease the mRNA stability or block translation to reduce the targeted gene expression (19, 20) , we were interested in elucidating how the amiR mimic decreases the targeted gene expression. For this purpose, we compared the effects of the amiR mimic or/and siRNA on the mRNA level of the targeted gene by using a real-time PCR approach. The results showed that although the protein level of the targeted gene (XRCC2 or XRCC4) between the cells treated with the amiR mimic and the cells treated with the siRNA did not show any apparent difference (Fig. 6A) , the mRNA level of the targeted gene (XRCC2 or XRCC4) was lower in the cells treated with siRNA (~30% of control level) than in the cells treated with amiR mimic (~65% of the control level) (Fig. 6C) , suggesting that the effects of the amiR on reducing ~70% of the protein level of the targeted gene is through both decreasing the mRNA stability (~35%) and blocking translation (~35%). When compared with siRNA alone, combining the amiR and siRNA did not further decrease the mRNA stability (~30%) although the combined approach did further decrease the protein level, suggesting that the additional effect to reduce the protein level by the combined approach is due to the two mechanisms that generate mRNA instability and block translation. (Fig. 6C) . These results further demonstrate that the combined approach is specifically and efficiently for knocking down a gene. Since these small RNAs use different mechanisms to knock down a gene, the combined usage could reach significant addictive inhibition of the targeted gene expression. 
Discussion
In this study, we show for the first time that our designed amiRs could efficiently knock down DNA repair gene: XRCC2 or XRCC4, sensitize human tumor cells to radiation-induced killing, and combining with siRNA could more efficiently knock down the gene and radiosensitize human tumor cells.
A natural miRNA binding to the 3'-UTR of a gene is in a partial-complementary manner (21, 22) and one miRNA could target multiple genes (23); so, delivering a miRNA into cells and upregulating the miRNA could result in multiple un-expected effects on the cells' fate. An amiR in a perfect complementary manner, however, could avoid the un-expected side effects by limiting its real target. The results showed that our designed amiRs could efficiently knock down the target genes without affecting the cells growth, suggesting that the amiRs specifically knocked down the target genes. Since most human genes are regulated by miRNA (24) , it suggests that most human genes are available to be targeted by a designed amiR. It was reported that the manner of imperfect-complementary binding to 3'-UTR might protect the miRNA from an RNase degradation in Drosophila (25) , suggesting that the perfect-complementary binding manner (to 3'-UTR of the target gene) of amiRs might affect the stability of the amiRs. To examine the possibility, we designed the XRCC4 amiRs with imperfect-complementary binding sequences (containing 7 mismatched nucleotides (nt), which is similar to a natural miRNA) to the 3'-UTR (Supplementary Fig. S3A) . We transfected the different XRCC4-amiRs to A549 cells and compared the targeting efficiency as well as the stability of the amiRs. We did not find differences in XRCC4 knock down efficiency ( Supplementary Fig. S3B ) or stability of the amiRs (data not shown), suggesting that different from Drosophila miRNA stability, the human 
miRNA stability depends less on the match sequence to a targeted 3'UTR, which might be due to the relatively short 3'UTR and a simpler structure of the genome in Drosophila when compared with that in humans (26, 27). However, the real mechanism underlying the difference in miRNA degradation between humans and Drosophila need more studies to provide direct evidence. In this study, we found that the efficiency of knocking down the targeted gene dramatically reduced when we mixed an amiR mimic with a siRNA that had more than five matched nucleotides (data not shown), suggesting that these small RNAs could inter-bind each other and we should avoid the interaction among themselves.
Since NHEJ is a relatively fast process and is not affected by cell cycle distribution (28, 29),
The γ-H2AX positive ratios in the irradiated cells containing XRCC4 amiR was higher than that in the irradiated cells containing the vector alone, especially at 6 h after IR (Fig. 4A, B Author Manuscript Published OnlineFirst on January 11, 2012; DOI: 10.1158/0008-5472. CAN-11-2785 gene is more important than mildly targeting two genes because most human tumor cells are over-activated with one particular DNA repair pathway.
Taken together, our results show for the first time that combining amiR and siRNA to target both the non-coding and coding regions of XRCC2 or XRCC4 could more efficiently knock down the DNA DSB repair genes and sensitize human tumor cells to IR-induced killing. We believe that this combined approach will provide a broader use for knocking down any other genes (only if the gene contains more than 100 bp of the 3'-UTR) especially for those genes that are difficult to knock down by using only one approach; amiR or siRNA.
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